PSMB5 and breast carcinoma: also demonstrated in triple-negative breast cancer that PSMB5 is an indicator of poor prognosis and the silencing of the PSMB5 gene can increase the sensitivity of breast cancer cells to chemotherapy and subsequently to apoptosis (61).